RAF-MEK-ERK pathway in cancer evolution and treatment

R Ullah, Q Yin, AH Snell, L Wan - Seminars in cancer biology, 2022 - Elsevier
Abstract The RAF-MEK-ERK signaling cascade is a well-characterized MAPK pathway
involved in cell proliferation and survival. The three-layered MAPK signaling cascade is …

Targeting aberrant RAS/RAF/MEK/ERK signaling for cancer therapy

U Degirmenci, M Wang, J Hu - Cells, 2020 - mdpi.com
The RAS/RAF/MEK/ERK (MAPK) signaling cascade is essential for cell inter-and intra-
cellular communication, which regulates fundamental cell functions such as growth, survival …

Direct small-molecule inhibitors of KRAS: from structural insights to mechanism-based design

JML Ostrem, KM Shokat - Nature reviews Drug discovery, 2016 - nature.com
KRAS is the most frequently mutated oncogene in human cancer. In addition to holding this
distinction, unsuccessful attempts to target this protein have led to the characterization of …

Drugging the undruggable RAS: Mission possible?

AD Cox, SW Fesik, AC Kimmelman, J Luo… - Nature reviews Drug …, 2014 - nature.com
Despite more than three decades of intensive effort, no effective pharmacological inhibitors
of the RAS oncoproteins have reached the clinic, prompting the widely held perception that …

Small-molecule ligands bind to a distinct pocket in Ras and inhibit SOS-mediated nucleotide exchange activity

T Maurer, LS Garrenton, A Oh, K Pitts… - Proceedings of the …, 2012 - pnas.org
The Ras gene is frequently mutated in cancer, and mutant Ras drives tumorigenesis.
Although Ras is a central oncogene, small molecules that bind to Ras in a well-defined …

Targeting RAS signalling pathways in cancer therapy

J Downward - Nature reviews cancer, 2003 - nature.com
The RAS proteins control signalling pathways that are key regulators of several aspects of
normal cell growth and malignant transformation. They are aberrant in most human tumours …

Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer

PJ Roberts, CJ Der - Oncogene, 2007 - nature.com
Mitogen-activated protein kinase (MAPK) cascades are key signaling pathways involved in
the regulation of normal cell proliferation, survival and differentiation. Aberrant regulation of …

Ras history: The saga continues

AD Cox, CJ Der - Small GTPases, 2010 - Taylor & Francis
Although the roots of Ras sprouted from the rich history of retrovirus research, it was the
discovery of mutationally activated RAS genes in human cancer in 1982 that stimulated an …

Pharmacological targeting of RAS: recent success with direct inhibitors

JP O'Bryan - Pharmacological research, 2019 - Elsevier
RAS has long been viewed as undruggable due to its lack of deep pockets for binding of
small molecule inhibitors. However, recent successes in the development of direct RAS …

Rational design and characterization of a Rac GTPase-specific small molecule inhibitor

Y Gao, JB Dickerson, F Guo, J Zheng… - Proceedings of the …, 2004 - pnas.org
The signaling pathways mediated by Rho family GTPases have been implicated in many
aspects of cell biology. The specificity of the pathways is achieved in part by the selective …